UCB's Global Corporate Website
Welcome to UCB in the United States

Newsroom

Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results

 

 

UCB U.S. News

Collaboration with Duke University Focuses on Health Equity for Adolescents in Uganda

Read More

Employee Spotlight: Ian Crassweller – Leading and Evolving Through Change

Read More

Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial…

Read More

Twitter Feed

For More Information